Although the roles of eotaxin in ovarian cancer have not been extensively studied, it is known that eotaxin induction increases CD8-positive T cell recruitment to the TME in non-small lung cancer (Gao et al., 2019), promotes antitumor immunity and is associated with increased survival in colorectal cancer (Cao et al., 2021). The gene discussed is CCL11; the disease is ovarian carcinoma.